JP2003516421A - 置換フタロシアニン及びその前駆体 - Google Patents

置換フタロシアニン及びその前駆体

Info

Publication number
JP2003516421A
JP2003516421A JP2001543656A JP2001543656A JP2003516421A JP 2003516421 A JP2003516421 A JP 2003516421A JP 2001543656 A JP2001543656 A JP 2001543656A JP 2001543656 A JP2001543656 A JP 2001543656A JP 2003516421 A JP2003516421 A JP 2003516421A
Authority
JP
Japan
Prior art keywords
substituted
formula
optionally substituted
alkyl
phthalocyanine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001543656A
Other languages
English (en)
Japanese (ja)
Inventor
クック，マイケル，ジョン
ヒーニー，マーティン，ジェイムズ
Original Assignee
ジェンシャン・アクティーゼルスカブ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9929064.5A external-priority patent/GB9929064D0/en
Priority claimed from GBGB0025817.8A external-priority patent/GB0025817D0/en
Application filed by ジェンシャン・アクティーゼルスカブ filed Critical ジェンシャン・アクティーゼルスカブ
Publication of JP2003516421A publication Critical patent/JP2003516421A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0076—PDT with expanded (metallo)porphyrins, i.e. having more than 20 ring atoms, e.g. texaphyrins, sapphyrins, hexaphyrins, pentaphyrins, porphocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y10/00—Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B47/00—Porphines; Azaporphines
    • C09B47/04—Phthalocyanines abbreviation: Pc
    • C09B47/045—Special non-pigmentary uses, e.g. catalyst, photosensitisers of phthalocyanine dyes or pigments
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B47/00—Porphines; Azaporphines
    • C09B47/04—Phthalocyanines abbreviation: Pc
    • C09B47/06—Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide
    • C09B47/067—Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide from phthalodinitriles naphthalenedinitriles, aromatic dinitriles prepared in situ, hydrogenated phthalodinitrile
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B47/00—Porphines; Azaporphines
    • C09B47/04—Phthalocyanines abbreviation: Pc
    • C09B47/06—Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide
    • C09B47/067—Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide from phthalodinitriles naphthalenedinitriles, aromatic dinitriles prepared in situ, hydrogenated phthalodinitrile
    • C09B47/0673—Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide from phthalodinitriles naphthalenedinitriles, aromatic dinitriles prepared in situ, hydrogenated phthalodinitrile having alkyl radicals linked directly to the Pc skeleton; having carbocyclic groups linked directly to the skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Nanotechnology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Mathematical Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2001543656A 1999-12-08 2000-12-08 置換フタロシアニン及びその前駆体 Pending JP2003516421A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB9929064.5 1999-12-08
GBGB9929064.5A GB9929064D0 (en) 1999-12-08 1999-12-08 Substituted phthalocyanines and their precursors
GB0012348.9 2000-05-22
GB0012348A GB0012348D0 (en) 1999-12-08 2000-05-22 Substituted phthalocyanines and their precursors
GBGB0025817.8A GB0025817D0 (en) 1999-12-08 2000-10-20 Substituted phthalocyanines and their precursors
GB0025817.8 2000-10-20
PCT/GB2000/004708 WO2001042368A1 (en) 1999-12-08 2000-12-08 Substituted phthalocyanines and their precursors

Publications (1)

Publication Number Publication Date
JP2003516421A true JP2003516421A (ja) 2003-05-13

Family

ID=27255732

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001543656A Pending JP2003516421A (ja) 1999-12-08 2000-12-08 置換フタロシアニン及びその前駆体

Country Status (10)

Country Link
EP (1) EP1238016A1 (no)
JP (1) JP2003516421A (no)
AU (1) AU2192201A (no)
CA (1) CA2394891A1 (no)
CZ (1) CZ20021974A3 (no)
EE (1) EE200200298A (no)
HU (1) HUP0301099A3 (no)
NO (1) NO20022663L (no)
PL (1) PL355851A1 (no)
WO (1) WO2001042368A1 (no)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004529171A (ja) * 2001-03-21 2004-09-24 エル．モルテニ エ シー．デイ フラテッリ アリッチ ソシエタ’ディ エセルチヅィオ ソシエタ ペル アチオニ 金属置換非中心対称性フタロシアニン類似体、それらの調製、及び光線力学療法ならびに生体内診断における使用
JP2006528665A (ja) * 2003-05-14 2006-12-21 ユニヴェルシテ ド シャーブルック 医療における光線力学適用のための両親媒性トリスルホン化ポルフィラジン
JP2007091879A (ja) * 2005-09-29 2007-04-12 Fujifilm Corp ナフタロシアニン色素およびその製造方法
JP2007204405A (ja) * 2006-01-31 2007-08-16 Japan Science & Technology Agency 発光性カーボンナノホーン構成体と光線力学治療抗癌剤
JP2009067848A (ja) * 2007-09-11 2009-04-02 Nippon Shokubai Co Ltd アリール基含有フタロシアニン化合物及びその製造方法
JP2009215554A (ja) * 2008-03-10 2009-09-24 Xerox Corp フタロシアニン顔料のナノサイズ粒子
JP2012167189A (ja) * 2011-02-14 2012-09-06 Aisin Seiki Co Ltd フタロシアニン誘導体、フタロシアニン誘導体の製造方法および色素増感型太陽電池
JP2013193956A (ja) * 2012-03-15 2013-09-30 Saitama Univ ｔｅｔｒａｋｉｓ−トリアルキルまたはフェニルシリルエチニル置換フタロシアニンおよびその製造方法
JP2015089882A (ja) * 2013-11-06 2015-05-11 独立行政法人産業技術総合研究所 フタロシアニン化合物及び有機半導体材料
JP2017008194A (ja) * 2015-06-22 2017-01-12 山本化成株式会社 増感色素、半導体電極、光電変換素子および色素増感太陽電池
CN107778294A (zh) * 2016-08-24 2018-03-09 西诺拉股份有限公司 有机分子，特别应用于有机光电装置中
WO2018186489A1 (ja) * 2017-04-07 2018-10-11 山本化成株式会社 フタロシアニン系化合物、及びその用途
KR20180113914A (ko) * 2017-04-07 2018-10-17 제이에스알 가부시끼가이샤 고체 촬상 소자용 조성물, 적외선 차폐막 및 고체 촬상 소자
WO2020071470A1 (ja) * 2018-10-05 2020-04-09 山本化成株式会社 フタロシアニン系化合物、及びその用途
WO2022024926A1 (ja) * 2020-07-31 2022-02-03 住友化学株式会社 化合物
WO2022196089A1 (ja) * 2021-03-15 2022-09-22 ソニーグループ株式会社 リポソーム複合体、物質送達システム、物質送達方法及び光照射装置

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1346971B1 (en) 2002-03-18 2010-01-20 Sumitomo Chemical Company, Limited Production method for biarylalanine
CN100415715C (zh) * 2003-02-11 2008-09-03 杜锡光 紫菜嗪环中具有六个异吲哚结构亚单元的超酞菁类化合物、合成方法及用途
CZ303612B6 (cs) * 2010-08-19 2013-01-09 Výzkumný ústav organických syntéz a.s. Sloucenina pro fotodynamickou inaktivaci soucasne grampozitivních bakterií, gramnegativních bakterií a patogenních kvasinek, na bázi derivátu ftalocyaninu, a pouzití této slouceniny
CN103864645B (zh) * 2013-12-30 2016-08-17 常州大学 一种二取代全氟烷基邻苯二甲腈化合物及其制备方法
CN104016995A (zh) * 2014-06-26 2014-09-03 常州大学 八取代全氟烷基钴酞菁化合物及其制备方法
CN108017650A (zh) * 2017-03-08 2018-05-11 先尼科化工（上海）有限公司 一种用于滤光片的酞菁化合物及其制备方法和应用方法
US11174274B2 (en) * 2017-04-07 2021-11-16 Yamamoto Chemicals, Inc. Naphthalocyanine compound, method for producing same, and use thereof
CN112279856B (zh) * 2019-07-24 2021-09-17 南方科技大学 一种非外围取代的可溶性金属酞菁及其合成方法和应用、一种钙钛矿太阳能电池
CN112014383B (zh) * 2020-06-30 2024-03-29 杜旭忠 一种用于均相化学发光的光敏剂及其制备方法和应用
CN112812299B (zh) * 2020-12-31 2022-03-29 四川大学 邻苯二甲腈与氨基酸环肽共聚树脂及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0155780B1 (en) * 1984-03-21 1990-03-28 Imperial Chemical Industries Plc Infra-red absorber
GB8431446D0 (en) * 1984-12-13 1985-01-23 Secr Defence Alkoxyphthalocyanines
GB8619238D0 (en) * 1986-08-06 1986-09-17 Ici Plc Organic photoconductor
WO1988006175A1 (en) * 1987-02-13 1988-08-25 The Secretary Of State For Defence In Her Britanni Substituted phthalocyanines
JPH0730300B2 (ja) * 1988-04-01 1995-04-05 三井東圧化学株式会社 アルキルフタロシアニン近赤外線吸収剤及びそれを用いた表示・記録材料
EP0373643B1 (en) * 1988-12-15 1998-01-21 MITSUI TOATSU CHEMICALS, Inc. Near infrared absorbers and display/recording materials prepared by using same
JPH07103093B2 (ja) * 1989-01-12 1995-11-08 三井東圧化学株式会社 フタロニトリル系化合物およびその製造方法
CA2071474A1 (en) * 1991-06-19 1992-12-20 Hisato Itoh Phthalocyanine compounds and usage thereof
EP0616621B1 (en) * 1991-11-08 1996-12-18 Eastman Chemical Company Method for tagging thermoplastic materials with near infrared fluorophores
GB9317881D0 (en) * 1993-08-27 1993-10-13 Secr Defence Photosensitizers
US5456998A (en) * 1994-04-26 1995-10-10 Xerox Corporation Photoconductive imaging members containing alkoxy-bridged metallophthalocyanine dimers
JPH0892190A (ja) * 1994-09-26 1996-04-09 Kanto Chem Co Inc シアノビフェニル誘導体並びにそれらを含む液晶組成物
GB9613476D0 (en) * 1996-06-27 1996-08-28 British Polythene Ltd Improvements in or relating to films and/or coatings
IT1294325B1 (it) * 1997-08-14 1999-03-24 Molteni L E C Dei Fratelli Ali Zinco-ftalocianine e relativi coniugati, preparazione e uso nella terapia fotodinamica e come diagnostici
US6511971B1 (en) * 1998-10-13 2003-01-28 Brown University Research Foundation Substituted perhalogenated phthalocyanines

Cited By (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004529171A (ja) * 2001-03-21 2004-09-24 エル．モルテニ エ シー．デイ フラテッリ アリッチ ソシエタ’ディ エセルチヅィオ ソシエタ ペル アチオニ 金属置換非中心対称性フタロシアニン類似体、それらの調製、及び光線力学療法ならびに生体内診断における使用
JP2006528665A (ja) * 2003-05-14 2006-12-21 ユニヴェルシテ ド シャーブルック 医療における光線力学適用のための両親媒性トリスルホン化ポルフィラジン
JP4855937B2 (ja) * 2003-05-14 2012-01-18 ソシエテ デ コマーシャリセーション デス プロデューツ デ ラ リーサーシェ アプリケ エスオーシーピーアールエー−サイエンセス サンテ エ ヒューマネス エス．イー．シー． 医療における光線力学適用のための両親媒性トリスルホン化ポルフィラジン
JP2007091879A (ja) * 2005-09-29 2007-04-12 Fujifilm Corp ナフタロシアニン色素およびその製造方法
JP2007204405A (ja) * 2006-01-31 2007-08-16 Japan Science & Technology Agency 発光性カーボンナノホーン構成体と光線力学治療抗癌剤
JP2009067848A (ja) * 2007-09-11 2009-04-02 Nippon Shokubai Co Ltd アリール基含有フタロシアニン化合物及びその製造方法
JP2009215554A (ja) * 2008-03-10 2009-09-24 Xerox Corp フタロシアニン顔料のナノサイズ粒子
JP2012167189A (ja) * 2011-02-14 2012-09-06 Aisin Seiki Co Ltd フタロシアニン誘導体、フタロシアニン誘導体の製造方法および色素増感型太陽電池
JP2013193956A (ja) * 2012-03-15 2013-09-30 Saitama Univ ｔｅｔｒａｋｉｓ−トリアルキルまたはフェニルシリルエチニル置換フタロシアニンおよびその製造方法
JP2015089882A (ja) * 2013-11-06 2015-05-11 独立行政法人産業技術総合研究所 フタロシアニン化合物及び有機半導体材料
JP2017008194A (ja) * 2015-06-22 2017-01-12 山本化成株式会社 増感色素、半導体電極、光電変換素子および色素増感太陽電池
CN107778294A (zh) * 2016-08-24 2018-03-09 西诺拉股份有限公司 有机分子，特别应用于有机光电装置中
JP2018065784A (ja) * 2016-08-24 2018-04-26 サイノラ ゲゼルシャフト ミット ベシュレンクテル ハフ 特に有機光電子デバイスに使用するための有機分子
US11588114B2 (en) 2016-08-24 2023-02-21 Samsung Display Co., Ltd. Organic molecules for use in optoelectronic devices
US10665792B2 (en) 2016-08-24 2020-05-26 Cynora Gmbh Organic molecules for use in optoelectronic devices
CN107778294B (zh) * 2016-08-24 2021-07-09 西诺拉股份有限公司 有机分子，特别应用于有机光电装置中
KR20180113914A (ko) * 2017-04-07 2018-10-17 제이에스알 가부시끼가이샤 고체 촬상 소자용 조성물, 적외선 차폐막 및 고체 촬상 소자
WO2018186489A1 (ja) * 2017-04-07 2018-10-11 山本化成株式会社 フタロシアニン系化合物、及びその用途
JPWO2018186489A1 (ja) * 2017-04-07 2020-05-14 山本化成株式会社 フタロシアニン系化合物、及びその用途
CN110494501A (zh) * 2017-04-07 2019-11-22 山本化成株式会社 酞菁系化合物、及其用途
US11015061B2 (en) 2017-04-07 2021-05-25 Yamamoto Chemicals, Inc. Phthalocyanine-based compound and uses of same
JP2018180167A (ja) * 2017-04-07 2018-11-15 Jsr株式会社 固体撮像素子用組成物、赤外線遮蔽膜及び固体撮像素子
KR20190133760A (ko) 2017-04-07 2019-12-03 야마모토카세이 카부시키카이샤 프탈로시아닌계 화합물 및 그의 용도
CN110494501B (zh) * 2017-04-07 2022-04-19 山本化成株式会社 酞菁系化合物、及其用途
JP7128803B2 (ja) 2017-04-07 2022-08-31 山本化成株式会社 フタロシアニン系化合物、及びその用途
KR102558721B1 (ko) 2017-04-07 2023-07-24 제이에스알 가부시끼가이샤 고체 촬상 소자용 조성물, 적외선 차폐막 및 고체 촬상 소자
WO2020071470A1 (ja) * 2018-10-05 2020-04-09 山本化成株式会社 フタロシアニン系化合物、及びその用途
WO2022024926A1 (ja) * 2020-07-31 2022-02-03 住友化学株式会社 化合物
CN115916907A (zh) * 2020-07-31 2023-04-04 住友化学株式会社 化合物
CN115916907B (zh) * 2020-07-31 2023-11-28 住友化学株式会社 化合物
WO2022196089A1 (ja) * 2021-03-15 2022-09-22 ソニーグループ株式会社 リポソーム複合体、物質送達システム、物質送達方法及び光照射装置

Also Published As

Publication number Publication date
CZ20021974A3 (cs) 2002-11-13
NO20022663L (no) 2002-08-08
PL355851A1 (en) 2004-05-31
EE200200298A (et) 2003-08-15
CA2394891A1 (en) 2001-06-14
WO2001042368A1 (en) 2001-06-14
HUP0301099A2 (hu) 2003-08-28
AU2192201A (en) 2001-06-18
HUP0301099A3 (en) 2003-11-28
EP1238016A1 (en) 2002-09-11
NO20022663D0 (no) 2002-06-05

Similar Documents

Publication Publication Date Title
JP2003516421A (ja) 置換フタロシアニン及びその前駆体
Hu et al. Hydroxyphthalocyanines as potential photodynamic agents for cancer therapy
JP3228296B2 (ja) β，β’−ジヒドロキシメソ置換クロリン、イソバクテリオクロリン、バクテリオクロリン、およびβ，β’−非置換テトラピロールマクロサイクルからのそれらの製造方法
JPH089621B2 (ja) 光力学的な治療法に有用な精製されたヘマトポルフィリン二量体および三量体
JPS6183186A (ja) 新規なテトラピロ−ル医薬用組成物
JPH07505614A (ja) ピロフェオホルビド類および光力学療法におけるそれらの使用
JPH0794392B2 (ja) 新規なテトラピロ−ルポリアミノモノカルボン酸医薬用組成物
US5703230A (en) Meso-monoiodo-substituted tetramacrocyclic compounds and methods for making and using the same
Wöhrle et al. Synthesis and photochemical properties of phthalocyanine zinc (II) complexes containing o-carborane units
JP2003515538A (ja) クロロフィル及びバクテリオクロロフィルのエステル類、その調製及びそれを含む医薬組成物
EP2940021B1 (en) Cyanine dye compound and preparation method therefor, and dual-function agent for photodynamic therapy and preparation method therefor
Xiang et al. Synthesis, spectral properties of rhodanine complex merocyanine dyes as well as their effect on K562 leukemia cells
CN113831351B (zh) 一类新型四吡咯衍生物及其应用
KR20190125007A (ko) 광감각제, 광감각제를 포함하는 조성물 및 광역동 치료 방법
WO2002096913A1 (en) Substituted di(hydroxy/alkoxy)silicon phthalocyanines and their uses
Li et al. Cobaltacarborane–phthalocyanine conjugates: Syntheses and photophysical properties
Easson et al. Synthesis and in vitro properties of trimethylamine-and phosphonate-substituted carboranylporphyrins for application in BNCT
US20050107335A1 (en) Compounds useful as photodynamic therapeutic agents
CN114409687B (zh) 一种可在肿瘤内切换光治疗模式的光敏药物及其制备方法和应用
Bhupathiraju et al. Synthesis and toxicity of cobaltabisdicarbollide-containing porphyrins of high boron content
CA2399217A1 (en) Porphyrins and related compounds
Peng et al. Synthesis, separation and characterization of amphiphilic 2, 10-di-sulfonato-18, 26-di-phthalimidomethyl phthalocyanine zinc di-potassium salt by template reaction
EP3870558A1 (fr) Nouveaux composés et leurs utilisations pour l'imagerie par la luminescence cherenkov proche infrarouge et/ou pour le traitement des tissus profonds par photothérapie dynamique cherenkov
JPH05501857A (ja) 感光性ディールス―アルダーポルフィリン誘導体
CN103705532B (zh) 靶向胸苷激酶光敏剂及其药物组合物与治疗癌症的用途